Postpartum adiponectin concentration, insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances

Preventive Cardiology

Volumn 11, Issue 2, 2008, Pages 106-115

  Costacou, Tina ^a   Bosnyak, Zsolt ^a,b,c   Harger, Gail F ^a,d   Markovic, Nina ^a   Silvers, Nancy ^a   Orchard, Trevor J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Ferencvaros Health Care Service Diabetes Unit   (Hungary)

^c NOVO NORDISK A S   (Denmark)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; METABOLIC DISORDER; METABOLIC SYNDROME X; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; PULSE RATE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMPARATIVE STUDY; PREGNANCY; RISK FACTOR;

ADIPONECTIN; ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INSULIN RESISTANCE; METABOLIC SYNDROME X; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 45149129509     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2008.07512.x     Document Type: Article

References (52)

1. Seely EW. Hypertension in pregnancy: A potential window into long-term cardiovascular risk in women. J Clin Endocrinol Metab. 1999;84:1858-1861.
2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Gestational Diabetes Mellitus. Diabetes Care. 2004;27:S88-S90.
3. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM: implications for diagnosis and management. Diabetes. 1991;40:18-24.
4. Buchanan TA, Metzger BE, Freinkel N, et al. Insulin sensitivity and beta-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 1990;162:1008-1014.
5. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207-2213.
6. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88:2393-2398.
7. Fisher KA, Luger A, Spargo H. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine (Baltimore). 1981;60:267-276.
8. Bryans CI. The remote prognosis in toxemia of pregnancy. Clin Obstet Gynecol. 1966;9:973-990.
9. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999;341:1749-1756.
10. Heitritter SM, Solomon CG, Mitchell GF, et al. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2005;90:3983-3988.
11. Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32:47-50.
12. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein, adiponectin. Circulation. 1999;100:2473-2476.
13. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of sol-ubledefense collagens, negatively regulates the growth of myelomono-cyticdefense collagens, negatively regulates the growth of myelomono-cyticprogenitors and the functions of macrophages. Blood. 2000;96:1723-1732.
14. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-1935.
15. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595-1599.
16. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134-141.
17. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis. 2006;188: 231-244.
18. Ramsay JE, Jamieson N, Greer IA, et al. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension. 2003;42:891-894.
19. Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf). 2007;66:447-453.
20. McLachlan KA, O'Neal D, Jenkins A, et al. Do adiponectin, TNF-alpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev. 2006;22:131-138.
21. Asai-Sato M, Okamoto M, Endo M, et al. Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes. Endocr J. 2006;53:555-562.
22. Mazaki-Tovi S, Kanety H, Pariente C, et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007;27:77-81.
23. Hendler I, Blackwell SC, Mehta SH, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol. 2005;193:979-983.
24. Naruse K, Yamasaki M, Umekage H, et al. Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia. J Reprod Immunol. 2005;65: 65-75.
25. Girouard J, Giguegrave;re Y, Moutquin JM, et al. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension. 2007;49:1056-1062.
26. Retnakaran R, Connelly PW, Maguire G, et al. Decreased high-molecular-weight adiponectin in gestational diabetes: Implications for the pathophysiology of type 2 diabetes. Diabet Med. 2007;24:245-252.
27. Ness RB, Markovic N, Bass D, et al. Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol. 2003;102:1366-1371.
28. Bosnyak Z, Silvers N, Costacou T, et al. Post partum metabolic syndrome (MS) in women with pregnancy induced disturbances. Diabetes. 2004;53:A606.
29. Borhani NO, Kass EH, Langford HG, et al. The hypertension detection and follow-up program. Prev Med. 1976;5:207-215.
30. Orchard TJ, Dorman JS, Maser RE, et al. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care. 1990;13:741-747.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
32. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation. 2004;109:433-438.
33. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735-2752.
34. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [serial online]. 2006. http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Accessed July 15, 2006.
35. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
36. Pipkin FB. Risk factors for preeclampsia. N Engl J Med. 2001;344:925-926.
37. Solomon CG, Seely EW. Hypertension in pregnancy - a manifestation of the insulin resistance syndrome? Hypertension. 2001;37:232-239.
38. Forest JC, Girouard J, Masse J, et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol. 2005;105:1373-1380.
39. Pouta A, Hartikainen AL, Sovio U, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004;43:825-831.
40. Efendic S, Hanson U, Persson B, et al. Glucose tolerance, insulin release, and insulin sensitivity in normal-weight women with previous gestational diabetes mellitus. Diabetes. 1987;36:413-419.
41. Dornhorst A, Chan SP, Gelding SV, et al. Ethnic differences in insulin secretion in women at risk of future diabetes. Diabet Med. 1992;9:258-262.
42. Homko C, Sivan E, Chen X, et al. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab. 2001;86:568-573.
43. Ward WK, Johnston CL, Beard JC, et al. Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: Relationship to obesity. J Clin Endocrinol Metab. 1988;61:1039-1045.
44. Kautzky-Willer A, Prager R, Waldhausl W, et al. Pronounced insulin resistance and inadequate [beta]-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care. 1997;20:1717-1723.
45. Xiang AH, Peters RK, Trigo E, et al. Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes. 1999;48:848-854.
46. Kousta E, Lawrence NJ, Godsland IF, et al. Insulin resistance and [beta]-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf). 2003;59:289-297.
47. Wijeyaratne CN, Waduge R, Arandara D, et al. Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus. BJOG. 2006;113:1182-1187.
48. Carr DB, Utzschneider KM, Hull RL, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care. 2006;29:2078-2083.
49. Di Cianni G, Lencioni C, Volpe L, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev. 2007;23:135-140.
50. Kousta E, Efstathiadou Z, Lawrence NJ, et al. The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes. Diabetologia. 2006;49:36-40.
51. Lauenborg J, Mathiesen E, Hansen T, et al. The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab. 2005;90:4004-4010.
52. Looker H, Funahashi T, Krakoff J, et al. Relationship between serum adiponectin levels and measures of renal function in type 2 diabetes [abstract]. Diabetes. 2003;52:41A.